Creative Medical Technology Holdings Files Patent on AmnioStem Exosome Stroke Therapy

December 15, 2016 Leave a comment 2,466 Views

Creative Medical Technology Holdings (the “Company”) (OTCQB:CELZ) announced today filing of US patent application #62/400557 entitled “Treatment of Stroke by Amniotic Fluid Derived Stem Cell Conditioned Media and Products Derived Thereof.” The patent application covers the use of the Company’s ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: Creative Medical Technology Holdings

Creative Medical Technology Holdings Files Patent on AmnioStem Exosome Stroke Therapy

One-stop Exosome Characterization Services Are Updated at Creative Biolabs

Scaled isolation of mesenchymal stem/stromal cell-derived extracellular vesicles

A urine-based exosomal gene expression test stratifies risk of high-grade prostate cancer in men with prior negative prostate biopsy undergoing repeat biopsy

RAB31 has dual functions in the biogenesis of exosomes

Illumina to pay $8B to reacquire cancer blood test maker Grail

Postdoc position available – exosome biology and endothelial dysfunction